Name of the Project: New Generation of High-Throughput Glycoanalytical Services
Call for project proposals:
Increasing the development of new products and services arising from research and development activities
Contracts Ref. No. KK.01.2.1.01.0003
Project short description:
With this project „New Generation of High-Throughput Glycoservices (NovaGenGliko)“ GENOS will expand the range of its services, which is crucial for further development and market occupation. The ability to quickly adapt to customer requirements, a wide range of automated High-Throughput analyzes with the support of new analytical methods and the ability to analyze different biological samples will jointly influence market development and most importantly GENOS will be able to maintain high market share. High-throughput services will contribute to the optimization of glyco analysis and a significant reduction in the cost of each analysis.
In addition to new technological services, the project also brings a significant expansion of the GENOS production capacities, which will support the development of a new generation of drugs and bio-markers, and at the same time open the door to the development of personalized analysis.
University of Zagreb Faculty of Pharmacy and Biochemistry
University of Zagreb Faculty of Science
University of Rijeka, Department of Biotechnology
High-throughput services will contribute to the optimization of glyco analysis and a significant reduction in the cost of each analysis. One of the most important innovations of the project brings the spread of commercial glyco analyzes from humans to experimental animals and cell lines. GENOS will be the first in the world to offer high-throughput analytical services on other types of biological samples.
The project expected results
- Process for development of new high - Throughput services
- 3 new technological solutions adopted (LC-MS, KE and MALDI)
- 9 new commercial high- Throughput services (TRL 8)
- Validation will be carried out by applying high- Throughput services in the actual development of bio-markers where we expect successful development, and later patent protection of at least two bio-markers
Total value of the project: 24.022.928,63 HKR
EU grants amount: 17.927.218,21 HRK
Project implementation period:
From 03. 10. 2016. to 31. 05. 2020.
Contacts person for more informations:
prof. Gordan Lauc
For more informations on EU funds please visit: